Liquid nitrogen spray cryotherapy for intramucosal carcinoma and extensive gastric intestinal metaplasia with dysplasia

Background and Aims: Gastric intestinal metaplasia with dysplasia (GIM-D) that is visible as a discrete limited lesion on endoscopy is readily treated using endoscopic mucosal resection or endoscopic submucosal dissection. However, there are few options for more extensive and invisible dysplasia. Ab...

Full description

Bibliographic Details
Main Authors: Spencer Harris, MD, PhD, Matt Fasullo, MD, George Smallfield, MD, MSPH, MS, Tilak Shah, MD, MHS
Format: Article
Language:English
Published: Elsevier 2021-05-01
Series:VideoGIE
Online Access:http://www.sciencedirect.com/science/article/pii/S2468448121000047
_version_ 1797753951116853248
author Spencer Harris, MD, PhD
Matt Fasullo, MD
George Smallfield, MD, MSPH, MS
Tilak Shah, MD, MHS
author_facet Spencer Harris, MD, PhD
Matt Fasullo, MD
George Smallfield, MD, MSPH, MS
Tilak Shah, MD, MHS
author_sort Spencer Harris, MD, PhD
collection DOAJ
description Background and Aims: Gastric intestinal metaplasia with dysplasia (GIM-D) that is visible as a discrete limited lesion on endoscopy is readily treated using endoscopic mucosal resection or endoscopic submucosal dissection. However, there are few options for more extensive and invisible dysplasia. Ablating a wide swath of tissue with argon plasma coagulation or radiofrequency ablation can be challenging and carries risks, including postprocedure ulceration. Liquid nitrogen spray cryotherapy is an established treatment for dysplasia in Barrett’s esophagus, but its use for GIM-D has not been previously reported. Methods: Three patients with intramucosal adenocarcinoma and GIM-D underwent a total of 10 sessions of spray cryotherapy. In all cases, spray cryotherapy was performed after passing an orogastric decompression tube into the stomach for active suctioning. Ablations were performed in cycles of 20 to 40 seconds, with at least 45 seconds between cycles to allow for tissue thawing. Between 2 and 7 ablations were performed during each procedure. Before each procedure, Sydney protocol biopsy specimens were obtained. No patient reported any postprocedure adverse events. Results: The first patient underwent 3 sessions of spray cryotherapy; there was no evidence of GIM-D after 1 session, no evidence of gastric intestinal metaplasia after 3 sessions, and no recurrence after 29 months. The second patient underwent 5 sessions of spray cryotherapy; after 1 session there was no adenocarcinoma, and at 14 months there was only GIM-D. The third patient underwent 2 spray cryotherapy sessions, and after 1 session there was gastric intestinal metaplasia but no GIM-D. Conclusions: Very few treatment modalities exist for extensive GIM-D. We present 3 cases in which off-label spray cryotherapy was used to treat extensive high-grade dysplasia with good treatment effect and patient tolerance. This adds to the body of literature supporting spray cryotherapy as a safe, well-tolerated, and effective treatment for extensive GIM-D.
first_indexed 2024-03-12T17:26:25Z
format Article
id doaj.art-53b8593e14ec4914911d18f6cf279d82
institution Directory Open Access Journal
issn 2468-4481
language English
last_indexed 2024-03-12T17:26:25Z
publishDate 2021-05-01
publisher Elsevier
record_format Article
series VideoGIE
spelling doaj.art-53b8593e14ec4914911d18f6cf279d822023-08-05T05:16:27ZengElsevierVideoGIE2468-44812021-05-0165239242Liquid nitrogen spray cryotherapy for intramucosal carcinoma and extensive gastric intestinal metaplasia with dysplasiaSpencer Harris, MD, PhD0Matt Fasullo, MD1George Smallfield, MD, MSPH, MS2Tilak Shah, MD, MHS3Department of Internal Medicine, Virginia Commonwealth University Health System, Richmond, VirginiaDepartment of Internal Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Health System, Richmond, VirginiaDepartment of Internal Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Health System, Richmond, VirginiaDepartment of Internal Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Health System, Richmond, VirginiaBackground and Aims: Gastric intestinal metaplasia with dysplasia (GIM-D) that is visible as a discrete limited lesion on endoscopy is readily treated using endoscopic mucosal resection or endoscopic submucosal dissection. However, there are few options for more extensive and invisible dysplasia. Ablating a wide swath of tissue with argon plasma coagulation or radiofrequency ablation can be challenging and carries risks, including postprocedure ulceration. Liquid nitrogen spray cryotherapy is an established treatment for dysplasia in Barrett’s esophagus, but its use for GIM-D has not been previously reported. Methods: Three patients with intramucosal adenocarcinoma and GIM-D underwent a total of 10 sessions of spray cryotherapy. In all cases, spray cryotherapy was performed after passing an orogastric decompression tube into the stomach for active suctioning. Ablations were performed in cycles of 20 to 40 seconds, with at least 45 seconds between cycles to allow for tissue thawing. Between 2 and 7 ablations were performed during each procedure. Before each procedure, Sydney protocol biopsy specimens were obtained. No patient reported any postprocedure adverse events. Results: The first patient underwent 3 sessions of spray cryotherapy; there was no evidence of GIM-D after 1 session, no evidence of gastric intestinal metaplasia after 3 sessions, and no recurrence after 29 months. The second patient underwent 5 sessions of spray cryotherapy; after 1 session there was no adenocarcinoma, and at 14 months there was only GIM-D. The third patient underwent 2 spray cryotherapy sessions, and after 1 session there was gastric intestinal metaplasia but no GIM-D. Conclusions: Very few treatment modalities exist for extensive GIM-D. We present 3 cases in which off-label spray cryotherapy was used to treat extensive high-grade dysplasia with good treatment effect and patient tolerance. This adds to the body of literature supporting spray cryotherapy as a safe, well-tolerated, and effective treatment for extensive GIM-D.http://www.sciencedirect.com/science/article/pii/S2468448121000047
spellingShingle Spencer Harris, MD, PhD
Matt Fasullo, MD
George Smallfield, MD, MSPH, MS
Tilak Shah, MD, MHS
Liquid nitrogen spray cryotherapy for intramucosal carcinoma and extensive gastric intestinal metaplasia with dysplasia
VideoGIE
title Liquid nitrogen spray cryotherapy for intramucosal carcinoma and extensive gastric intestinal metaplasia with dysplasia
title_full Liquid nitrogen spray cryotherapy for intramucosal carcinoma and extensive gastric intestinal metaplasia with dysplasia
title_fullStr Liquid nitrogen spray cryotherapy for intramucosal carcinoma and extensive gastric intestinal metaplasia with dysplasia
title_full_unstemmed Liquid nitrogen spray cryotherapy for intramucosal carcinoma and extensive gastric intestinal metaplasia with dysplasia
title_short Liquid nitrogen spray cryotherapy for intramucosal carcinoma and extensive gastric intestinal metaplasia with dysplasia
title_sort liquid nitrogen spray cryotherapy for intramucosal carcinoma and extensive gastric intestinal metaplasia with dysplasia
url http://www.sciencedirect.com/science/article/pii/S2468448121000047
work_keys_str_mv AT spencerharrismdphd liquidnitrogenspraycryotherapyforintramucosalcarcinomaandextensivegastricintestinalmetaplasiawithdysplasia
AT mattfasullomd liquidnitrogenspraycryotherapyforintramucosalcarcinomaandextensivegastricintestinalmetaplasiawithdysplasia
AT georgesmallfieldmdmsphms liquidnitrogenspraycryotherapyforintramucosalcarcinomaandextensivegastricintestinalmetaplasiawithdysplasia
AT tilakshahmdmhs liquidnitrogenspraycryotherapyforintramucosalcarcinomaandextensivegastricintestinalmetaplasiawithdysplasia